A report from the Healthcare Supply Chain Association (HSCA) said the group purchasing organizations (GPOs) it represents help cut supply chain costs by an average of 15 percent and reduce drug spending by 25 percent.

Members of Congress don’t believe Mylan CEO Heather Bresch’s claim that the company makes only $50 profit per EpiPen, an autoinjector for allergic reactions which has shot up 400 percent in price since Mylan started selling it.

As local Zika transmissions continue to pop up in the U.S., HHS is ramping up efforts to combat the virus through awareness of its symptoms, its effects and how to stop its spread. Various agencies under the HHS umbrella held a Twitter Q&A surrounding these topics Aug. 30 using the hashtag #AtoZika. 

Based on new and re-analyzed data, it seems that maternal mortality rates jumped up almost 27 percent between 2000 and 2014 in the U.S, according to a new study published in the journal Obstetrics and Gynecology. That trend moved opposite to the trend of declining maternal mortality rates in the rest of the world and was directly opposed to the United Nations Millennium Development Goal of a 75 percent reduction in maternal mortality by 2015. It means the U.S. has one of the worst maternal mortality rates among developed countries. 

Traditional farming lifestyles, such as those held by the Amish in the U.S., can mitigate asthma and allergy risk factors, according to a new study in the New England Journal of Medicine. 

Hospital readmission rates are often used as indicators of the institutions’ effectiveness and getting and keeping patients healthy. It turns out, 30 percent of those short-term readmissions for children could be avoided, according to a new study in the journal Pediatrics. 

All over the world, the rate of new HIV/AIDS infections has stayed mostly the same in the last 10 years, Nature reports. The info comes from a new analysis in the journal The Lancet, which looked at infection trends from about 1980 to 2015. 

SAN FRANCISCO & TORONTO--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK), a leading international healthcare services and information technology company, and Katz Group, one of Canada’s largest privately-owned enterprises, today announced a definitive agreement to acquire Rexall Health from Katz Group for $3 billion CAD ($2.2 billion USD*, or approximately $1.9 billion USD* net of the present value of incremental cash tax benefits).